课题基金 / 基金详情

Novel strategies for genetic improvement of disease resistance in perennial ryegrass

Novel strategies for genetic improvement of disease resistance in perennial ryegrass
多年生黑麦草抗病性遗传改良的新策略
批准号:
102087
负责人:
金额:
$31.46万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
多年生黑麦草(PRG)为英国的牲畜提供了大部分饲料,并通过种子销售为萌芽控股(GHL)提供商业回报。anderchslera andersonii或网斑病是PRG的一种严重真菌疾病,英国处于高或中等风险。第一次刈割时,每公顷生物量产量下降可超过1dm。现有品种抗性好,英国高糖草(HSG)品种抗性差。使用杀菌剂不是一个可行的选择。减少HSG品种的使用将导致销售减少,增加抗性更高但糖含量不高的进口品种,从而提高反刍动物的营养效率,减少温室气体排放。例如,HSG种子销售减少20%将对GHL产生严重的商业影响。阿伯里斯特威斯大学IBERS将与GHL合作,利用基因组选择辅助的新回交策略,培育抗净斑病的HSG品种。这将提高抗病杂交种恢复先前农艺和HSG性状值的速度和可靠性,从而帮助GHL保持或增加市场份额。
英文摘要
Perennial ryegrass (PRG) provides the majority of forage for livestock in the UK, and delivers commercial returns to Germinal Holdings (GHL) through seed sales. Drechslera andersonii or net blotch is a serious fungal disease of PRG, and the UK is at high or medium risk. Biomass yield decreases can be more than 1t DM per hectare in the first cut. Few current varieties have good resistance, and the UK bred high sugar grass (HSG) varieties show poor resistance. Fungicide use is not a viable option. Reduction in the use of HSG varieties will lead to decreasing sales and increased imported varieties with higher resistance, but without the high sugar content, which improves ruminant nutrition efficiency and reduce GHG emissions from them. A 20% reduction in HSG seed sales for example would have serious commercial implications for GHL. IBERS, Aberystwyth University will collaborate with GHL to breed net blotch resistant HSG varieties using a novel backcross strategy aided by genomic selection. This will increase the speed and reliability with which disease resistant hybrids recover previous values of agronomic and HSG traits, and thus help GHL maintain or increase market share.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Scalable Learning and Optimization: High-dimensional Models and Online Decision-Making Strategies for Big Data Analysis
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
  • 批准号:
    82372743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈卓佳
  • 依托单位:
面向人工智能生成内容的风险识别与治理策略研究
  • 批准号:
    72304290
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    向安玲
  • 依托单位:
放疗通过激活GSDMD诱发细胞焦亡促进肿瘤再增殖的机制研究及干预策略探讨
  • 批准号:
    82373299
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    程进
  • 依托单位: